Sudha Vishwanath, a Tax Principal, has over 20 years of experience in the field.
Working in the Life Sciences industry, she helps to minimize taxes payable while ensuring compliance. She focuses on providing tax services to a wide range of corporate clients in the Life Sciences, Technology, and Professional Services Industries. Additionally, Sudha specializes has extensive experience in tax matters relating to closely held corporations, pass-through entities, and their owners.
Sudha is a member of the Fellowship program, which allows for client-facing audit and tax team members to play a key role in the firmwide staff training, at Withum. She is licensed in Massachusetts and is a CPA Chartered Accountant in India.
Learn more about my professional experience and how I spend my time outside the firm.
Education:
Professional Affiliations:
Sudha is actively involved with tax training and serves as a mentor for rising tax professionals. She shares her expansive knowledge and assists professionals with tax training across industries.
In his spare time, Sudha enjoys cooking, spending time with family, and traveling the world.
An analysis of the state individual income tax rate trends shows more states moving away from graduated tax rates to flat rate. Currently, 29 states have graduated individual tax rates, and 9 states have no individual income tax. The remaining 12 states have adopted a flat individual tax rate. Arizona and Idaho adopted flat rates…
Generic drugs typically cost less than the replicated brand-name drugs. It is a cost-effective way of making available expensive essential medications to patients who need them. Generic drugs are priced lower because manufacturers of generic drugs do not have to invest in clinical studies and tests that have already been done by the brand-name manufacturer….
In the life sciences sector, the journey from research to a marketable product often spans several years. During this phase, entities typically accrue substantial Net Operating Losses (NOLs), earmarked to counterbalance future taxable income. A pivotal change emerged on January 1, 2022. Research and Experimentation (R&E) expenditures, once directly deductible, now must be capitalized for…